Asklepios Group sees stable development in first half, set for closer cooperation within hospital network

Despite the still challenging policy and economic environment, Asklepios Kliniken GmbH & Co. KGaA reported a stable operating performance in the first half of 2025. The Group continued its strategic initiatives to ensure delivery of medical care and operating performance through efficiency gains, investments in digital infrastructure as well as quality standards. 

During the period from January to June 2025, 1,931,218 patients were treated in the healthcare facilities of the Asklepios Group (6M 2024: 1,818,146). The Group generated revenues of EUR 3,148.1 million (6M 2024: EUR 2,902.6 million).

In what continues to be a challenging market environment with rising material costs and employee expenses, some of the cost increases were offset – thanks in particular to the close cooperation within the Group. Consolidated net income for the period after taxes and levies (EAT) stood at EUR 86.3 million (6M 2024: EUR 74.1 million), with the EAT, at 2.7%, remaining roughly at the previous year’s level (6M 2024: 2.6%). 

Marco Walker, CEO of Asklepios Kliniken: “In the first half, the Asklepios Group has once again proven that we perform successfully also in difficult market conditions. Our efforts geared towards steadfastly pursuing our transformation course early on, consistently exploiting synergies and making targeted investments in digitalisation are paying off.  Together with Mediclin AG and Rhön-Klinikum AG, we provide the highest standard of medical care every day at our around 160 healthcare facilities under economically sustainable conditions.”

Joachim Gemmel, CEO of Asklepios Kliniken: “Early on, we recognised the changes in the healthcare system as an opportunity. With our focus on patient-oriented medicine, we put the health of our patients first, not case numbers. This approach is rigorously followed in all the services we provide covering prevention, diagnosis, treatment and after-care. At the same time we will grow even closer together as a Group in future to continue being a reliable partner in providing patients with the best possible care.”